SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-21-007093
Filing Date
2021-06-21
Accepted
2021-06-21 16:58:08
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 ndra_424b5.htm 424B5 384132
2 IMAGE ndra_424b5.jpg GRAPHIC 7040
3 IMAGE ndra_424b5000.jpg GRAPHIC 6824
4 IMAGE ndra_424b5001.jpg GRAPHIC 8043
5 IMAGE ndra_424b5002.jpg GRAPHIC 28965
6 IMAGE ndra_s3000.jpg GRAPHIC 12779
7 IMAGE ndra_s3001.jpg GRAPHIC 12675
  Complete submission text file 0001654954-21-007093.txt   491168
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254711 | Film No.: 211031529
SIC: 3845 Electromedical & Electrotherapeutic Apparatus